Skip to main content

Fred E. Cohen, M.D., D. Phil

Equibles does not estimate personal net worth.

Get an email with a short summary when CareDx, Inc. publishes a filing, an earnings call transcript or a press release.

Get CDNA alerts

About Fred E. Cohen, M.D., D. Phil

Fred E. Cohen, M.D., D. Phil is recorded as Board Member at CareDx, Inc. (CDNA) since June 12, 2025. CareDx, Inc. reported in an 8-K filed June 15, 2026 that Fred E. Cohen, M.D., D. Phil was appointed Class II director, effective June 11, 2026. CareDx, Inc. reported in an 8-K filed June 12, 2025 that Fred E. Cohen, M.D., D. Phil was appointed Class II director, effective June 12, 2025. CareDx, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at CareDx, Inc. includes Alexander L. Johnson (CEO), John W. Hanna (CEO and Board Member), Michael D. Goldberg (Chairman and Board Member) and 7 others.

“Each of the five nominees for director was elected to serve until the Company's 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified, or until such director's earlier death, resignation or removal.”
CareDx, Inc. Form 8-K, filed June 15, 2026 · Read the filing
“As a result, the Company’s stockholders voted to elect each of Fred E. Cohen, M.D., D. Phil and R. Bryan Riggsbee as Class II directors to serve until the Company’s 2026 annual meeting of stockholders or until his respective successor is duly elected and qualified.”
CareDx, Inc. Form 8-K, filed June 12, 2025 · Read the filing

Affiliation history

Company network

Current role

Diagnostics & Research · Healthcare

Board Member

2025-06-12–present

Leadership on record at CareDx, Inc.

Recent activity